Copyright
©2011 Baishideng Publishing Group Co.
World J Diabetes. Feb 15, 2011; 2(2): 24-32
Published online Feb 15, 2011. doi: 10.4239/wjd.v2.i2.24
Published online Feb 15, 2011. doi: 10.4239/wjd.v2.i2.24
Criteria | Comments |
Severity of infection | Broad-spectrum therapy via parenteral route for severe infection |
Renal dysfunction | Avoid nephrotoxic agents (aminoglycosides, glycopeptides) |
Hepatic dysfunction | Avoid hepatotoxic agents (macrolides, amoxicillin/clavulanate) |
Ischemic limb | Use relatively high doses of oral antibiotics or prefer IV route to achieve adequate antibiotic level at the site of infection if revascularization procedure is unfeasible |
Consider anti-anaerobic bacteria when there is ischaemia or extensive devitalized tissue | |
Impaired gastrointestinal function (gastroparesis) | Prefer parenteral route |
Local antibiotic resistance patterns | Cover MRSA if indicated |
Drug allergies | Review patient's medical history carefully |
History of recent antibiotic treatment | May need an extended coverage against gram-negative bacilli and Enterococcus |
Chronicity of the wound | Give preference to broad-spectrum therapy initially |
Poor therapeutic compliance | Consider IV route and/or hospitalization |
- Citation: Richard JL, Sotto A, Lavigne JP. New insights in diabetic foot infection. World J Diabetes 2011; 2(2): 24-32
- URL: https://www.wjgnet.com/1948-9358/full/v2/i2/24.htm
- DOI: https://dx.doi.org/10.4239/wjd.v2.i2.24